Advertisement

Vaccines against Rabies Virus

  • Paul Pierre Pastoret
  • Bernard Brochier
  • Gille Chappuis
  • Philippe Desmettre
Part of the Progress in Vaccinology book series (VACCINOLOGY, volume 4)

Abstract

Rabies is one of the oldest recognized diseases. It most probably originated on the African continent and diffusion in North Africa was followed by the spread throughout Europe and Asia. The disease subsequently appeared on the North American continent possibly by transmission through circumpolar animals such as foxes and wolves, though the importation of rabid dogs from Europe is also probable. Today rabies is a disease of major importance, present on all five continents (59,111).

Keywords

Rabies Virus Oral Immunization Oral Vaccination Rabies Vaccine Procyon Lotor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abelseth MK: Propagation of rabies virus in pig kidney cell culture. Can Vet J 1964; 5: 84–87.PubMedGoogle Scholar
  2. 2.
    Abelseth MK: An attenuated rabies vaccine for domestic animals produced in tissue cultures. Can Vet J 1964; 5: 279–286.PubMedGoogle Scholar
  3. 3.
    Andral L, Sérié C: Etudes expérimentales sur la rage en Ethiopie. Ann Inst Pasteur 1965; 108: 442–450.Google Scholar
  4. 4.
    Artois M, Charlton KM, Tolson ND, Casey GA, et al: Vaccinia recombinant virus expressing the rabies virus glycoprotein: safety and efficacy trials in canadian wildlife. Can J Vet Res 1990; 54: 504–507.PubMedGoogle Scholar
  5. 5.
    Atanasiu P, Metianu T, Bolanos A: Evaluation d’une vaccination rabique expérimentale par la voie orale et intestinale avec des vaccins tués, concentrés et non concentrés. Comp Immun Microbiol infect Dis 1982; 5: 187–191.Google Scholar
  6. 6.
    Baer GM, Linhart SB, Dean DJ: Rabies vaccination of foxes. Annu Rep Div Lab Res NY 1963; 49–50.Google Scholar
  7. 7.
    Baer GM, Abelseth MK, Debbie JG: Oral vaccination of foxes against rabies. Am J Epidemiol 1975; 93: 487–490.Google Scholar
  8. 8.
    Baer GM: Rabies vaccination of wildlife and domestic animals other than dogs. In: Kluwert E, Mérieux C, Koprowski H, Bögel K (eds): Rabies in the Tropics. New York: Springer-Verlag, 1985, p 270.Google Scholar
  9. 9.
    Bellinger DA, Chang J, Bunn TO, Dick JR, et al: Rabies induced in cats by high-egg-passage Flury strain vaccine. J Am Vet Med Assoc 1983; 183: 997–998.PubMedGoogle Scholar
  10. 10.
    Black JG, Lawson KG: Further studies of sylvatic rabies in the fox (Vulpes vulpes). Vaccination by the oral route. Can Vet J 1973; 14: 206–211.PubMedGoogle Scholar
  11. 11.
    Black JG, Lawson KG: The safety and efficacy of immunizing foxes (Vulpes vulpes) using bait containing attenuated rabies virus vaccine. Can J Comp Med 1980; 44: 169–176.PubMedGoogle Scholar
  12. 12.
    Blancou J, Aubert MFA, Andral L, Artois M: Rage expérimentale du renard roux (Vulpes vulpes). I. Sensibilité selon la voie d’infection et la dose infectante. Rev Méd Vét 1979; 13: 1001–1005.Google Scholar
  13. 13.
    Blancou J, Andral L, Aubert MFA, Artois M: Vaccination du renard contre la rage par voie orale. Bilan des essais réalisés en France. Bull Acad Vét Fr 1982; 55: 351–359.Google Scholar
  14. 14.
    Blancou J: La rage du renard. Ann Méd Vét 1985; 129: 293–307.Google Scholar
  15. 15.
    Blancou J: Vaccines and vaccination against rabies for domestic and wild animals in Europe. Rev Sci Tech Off Int Epiz 1985; 4: 249–259.Google Scholar
  16. 16.
    Blancou J, Kiény MP, Lathé R, Lecocq JP, et al: Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature (London) 1986; 322: 373–375.Google Scholar
  17. 17.
    Blancou J, Pastoret PP, Brochier B, Thomas I, et al: Vaccinating wild animals against rabies. Rev Sci Tech Off Int Epiz 1988; 7: 1005–1013.Google Scholar
  18. 18.
    Bourhy H, Tordo N, Lafon M, Sureau P: Complete cloning and molecular organization of a rabies related virus: Mokola virus. J Gen Virol 1989; 70: 2063–2074.PubMedGoogle Scholar
  19. 19.
    Bourhy H, Sureau P, Tordo N: From rabies to rabies-related viruses. Vet Microbiol 1990; 23: 115–128.PubMedGoogle Scholar
  20. 20.
    Brochier B, Godfroid J, Costy F, Blancou J, et al: Vaccination of young foxes (Vulpes vulpes) against rabies: Trials with inactivated vaccine administered by oral and parenteral routes. Ann Rech Vet 1985; 16: 327–333.PubMedGoogle Scholar
  21. 21.
    Brochier B, Languet B, Blancou J, Kiény MP, et al: Use of recombinant vaccinia-rabies virus for oral vaccination of fox cubs (Vulpes vulpes L.) against rabies. Vet Microbiol 1988; 18: 103–108.PubMedGoogle Scholar
  22. 22.
    Brochier B, Thomas I, Iokem A, Ginter A, et al: A field trial in Belgium to control fox rabies by oral immunisation. Vet Rec 1988; 123: 618–621.PubMedGoogle Scholar
  23. 23.
    Brochier B, Blancou J, Aubert MFA, Kiény MP, et al: Interaction between rabies infection and oral administration of vaccinia-rabies recombinant virus to foxes (Vulpes vulpes). J Gen Virol 1989; 70: 1601–1604.PubMedGoogle Scholar
  24. 24.
    Brochier B, Blancou J, Thomas I, Languet B, et al: Use of recombinant vaccinia-rabies glycoprotein virus for oral vaccination of wildlife against rabies: Innocuity to several non-target bait consuming species. J Wildl Dis 1989; 25: 540–547.PubMedGoogle Scholar
  25. 25.
    Brochier B, Languet B, Artois M, Zanker S, et al: Efficacy of a baiting system for fox vaccination against rabies with vaccinia-rabies recombinant virus. Vet Rec 1990; 127: 165–167.PubMedGoogle Scholar
  26. 26.
    Brochier B, Thomas I, Bauduin B, Leveau T, et al: Use of vaccinia-rabies recombinant virus for the oral vaccination of foxes against rabies. Vaccine 1990; 8: 101–104.PubMedGoogle Scholar
  27. 27.
    Brochier B, Kiény MP, Costy F, Coppens P, Bauduin B, Lecocq JP, Languet B, Chappuis G, Desmettre P, Afiademanyo K, Libois R, Pastoret PP: Large-scales eradication of rabies using recombinant vaccinia-rabies vaccine. Nature, 1991; 354: 520–522.PubMedGoogle Scholar
  28. 28.
    Bunschotten H: The immune response to rabies virus idiotypes and regulation. Thesis, University of Utrecht, 1989.Google Scholar
  29. 29.
    Bussereau F, Aubert M, Blancou J: Temperature-sensitive mutants of rabies virus: behaviour following inoculation into mouse and fox. Ann Inst Pasteur/Virol 1983; 134E: 315–325.Google Scholar
  30. 30.
    Charlton K: The pathogenesis of rabies, In: Campbell JB, Charlton K (eds): Rabies. Developments in Veterinary Virology. Dordrecht: Kluwer Academic Publishers, 1988.Google Scholar
  31. 31.
    Ciuchini F, Pestalozza S, Buonavoglia C, Ditrani L, et al: Reisolamento del virus vaccinale rabido SAD/BHK-21 da volpi rosse trattate per via orale, stotto efetto corticoide. Atti Soc Ital Sci Vet 1984; 38: 707–710.Google Scholar
  32. 32.
    Ciuchini F, Pestalozza S, Buonavoglia C, Ditrani L, et al: Ricerche su di un vaccino allestito con lo stipite SAD/BHK-21 (Berna) del virus della rabbis da impiegare per la vaccinazione della volpe. Clinica Vet 1985; 108: 219–230.Google Scholar
  33. 33.
    Correa-Giron EP, Allen R, Sulkin SE: The infectivity and pathogenesis of rabies virus administered orally. Am J Epidemiol 1970; 91: 203–215.PubMedGoogle Scholar
  34. 34.
    Coulon P, Rollin P, Blancou J, Flamand A: Avirulent mutants of the CVS strain of rabies virus. Comp Immun Microbiol Infect Dis 1982; 5: 117–122.Google Scholar
  35. 35.
    Coulon P, Rollin P, Blancou J, Flamand A: Molecular basis of rabies virus virulence. I. Selection of avirulent mutants of the CVS strain with anti-G monoclonal antibodies. J Gen Virol 1982b; 61: 97–100.PubMedGoogle Scholar
  36. 36.
    Coulon P, Rollin P, Flamand A: Molecular basis of rabies virus virulence. II. Identification of a site on the CVS glycoprotein associated with virulence. J Gen Virol 1983; 64: 693–696.PubMedGoogle Scholar
  37. 37.
    Cox JH, Dietzschold B, Weiland F, Schneider LG: Preparation and characterization of rabies virus hemagglutinin. Infect Immun 1980; 30: 57 2577.Google Scholar
  38. 38.
    Dean DJ, Guevin VH: Rabies vaccination of cats. J Am Vet Med Assoc 1963; 142: 367.PubMedGoogle Scholar
  39. 39.
    Desmettre P, Languet B, Chappuis G, Brochier B, et al: Use of vaccinia rabies recombinant for oral vaccination of wildlife. Vet Microbiol 1990; 23: 227–236.PubMedGoogle Scholar
  40. 40.
    Desmettre P, Chappuis G: Vaccins et vaccination. In: Pastoret PP, Govaerts A, Bazin H (eds): Immunologie Animale. Paris: Flammarion, Médecine-Sciences, 1990.Google Scholar
  41. 41.
    Bietzschold B, Wunner WH, Wiktor TJ, Lopes AD, et al: Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci USA 1983; 80: 70.Google Scholar
  42. 42.
    Dubreuil M, Andral L, Aubert MFA, Blancou J: The oral vaccination of foxes against rabies. An experimental study. Ann Rech Vet 1979; 10: 9–21.PubMedGoogle Scholar
  43. 43.
    Esch JB, Cunningham JG, Wiktor TJ: Vaccine-induced rabies in four cats. J Am Vet Med Assoc 1982; 180: 1336.Google Scholar
  44. 44.
    Esposito JJ, Brechling K, Baer G, Moss B: Vaccinia virus recombinants expressing rabies virus glycoprotein protect against rabies. Virus Genes 1987; 1: 7–21.PubMedGoogle Scholar
  45. 45.
    Esposito JJ, Knight JC, Shaddock JH, Novembre FJ, et al: Successful oral rabies vaccination of raccoons with raccoon poxvirus recombinants expressing rabies virus glycoprotein. Virology 1988; 165: 313–316.PubMedGoogle Scholar
  46. 46.
    Fekadu M, Shaddock JH, Baer GM: Intermittent excretion of rabies virus in the saliva of a dog two and six months after it had recovered from experimental rabies. Am J Trop Med Hyg 1981; 30: 1113.PubMedGoogle Scholar
  47. 47.
    Fermi C: Uber die Immunisierung gegen Wutkrankheit. Z Hyg Infekt Krankh 1908; 58: 233–276.Google Scholar
  48. 48.
    Flamand A, Blancou J, Coulon P, Lafay F, et al: The antigenic structure of the rabies glycoprotein. Application of basic research to oral vaccination of foxes. 2nd Essen Symposium “New developments in rabies control,” Essen, RFA, 1988, 5–7 July.Google Scholar
  49. 49.
    Fox JL: Rabies vaccine field test undertaken. ASM News 1990; 56: 579–583.Google Scholar
  50. 50.
    Frost JW, Friederich H, Wachendorfer G: Effectivity of oral vaccination of foxes against rabies with Flury HEP strain 675. Comp Immun Microbiol infect Dis 1982; 5: 181–184.Google Scholar
  51. 51.
    Fuenzalida E, Palacios R: Rabies vaccine prepared from brains of infected suckling mice. Biol Inst Bacteriol 1955: 8: 3–10.Google Scholar
  52. 52.
    Galtier V: Deuxième note sur la rage. CR Hebd Séance Acad Sci Paris 1879; 89: 444.Google Scholar
  53. 53.
    Galtier V: Les injections de virus rabique dans le torrent circulatoire ne provoquent pas l’éclosion de la rage et semblent conférer l’immunité. La rage peut être transmise par l’ingestion de la matière rabique. CR Acad Sci 1881; 93: 284–285.Google Scholar
  54. 54.
    Hanlon CA, Ziemer EL, Hamir AN, Rupprecht CE: Cerebrospinal fluid analysis of rabid and vaccinia-rabies glycoprotein recombinant, orally vaccinated raccoons (Procyon lotor). Am J Vet Res 1989; 50: 364.PubMedGoogle Scholar
  55. 55.
    Hoglund S, Dalsgaard K, Lovgren K, Sundquist B, et al: ISCOMs and immunostimulation with viral antigens. In: Harris JR (ed): Subcellular Biochemistry, Vol. 15. New York: Plenum, 1989.Google Scholar
  56. 56.
    Humphrey GL, Bayer EV, Constantin DG: Canine rabies vaccine virus infection. Review of the probable risk of such infections in vaccinated dogs in California during the 4-year period 1973–1977. Calif Vet 1978; July 13.Google Scholar
  57. 57.
    Kiefert C, Wachendorfer G, Frost JW: Unschädlich keitsprüfungen mit der Geklonten Variante des Flury-HEP-Virus (Stamm 675) bei wildlebenden Spezies. Ein Beitrag zur oralen Immuniesierung von Füchsen gegen Tollwut. Tierärztl Umsch 1982; 37: 165–176.Google Scholar
  58. 58.
    Kiény MP, Lathé R, Drillien R, Spehner D, et al: Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature (London) 1984; 312: 163–166.Google Scholar
  59. 59.
    Kiény MP, Desmettre P, Soulebot JP, Lathé R: Rabies vaccine: Traditional and novel approaches. Prog Vet Microbiol Immun 1987; 3: 73–111.Google Scholar
  60. 60.
    King A, Davies P, Lawrie A: The rabies viruses of bats, Vet Microbiol 1990; 23: 165–174.PubMedGoogle Scholar
  61. 61.
    Koprowski H, Cox HR: Studies on chick embryo adapted rabies virus. J Immun 1948; 60: 533–554.PubMedGoogle Scholar
  62. 62.
    Koprowski H, Black J: Studies on chick embryo adapted virus. II. Pathogenicity for dogs and use of egg-adapted strains for vaccination purposes. J Immun 1950; 64: 185.PubMedGoogle Scholar
  63. 63.
    Koprowski H: Biological modification of rabies virus as a result of its adaptation to chicks and developing chick embryos. Bull Wldl Hlth Org 1954; 10: 709–724.Google Scholar
  64. 64.
    Koprowski H, Reagan KJ, McFarlan RI, Dietzschold B, et al: New generation of rabies vaccines: rabies glycoprotein gene recombinants, antiidiotypic antibodies, and synthetic peptides. In: Lerner RA, Chanock RM, Brown F (eds): Vaccines 85: Molecular and Chemical Basis of Resistance to Parasitic, Bacterial and Viral Diseases. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1985, pp 151–156.Google Scholar
  65. 65.
    Lawson KF, Black JG, Charlton KM, Johnston DH, et al: Safety and immunogenicity of a vaccine bait containing ERA strain of attenuated rabies virus. Can Vet J 1987; 51: 460–464.Google Scholar
  66. 66.
    Leblois H, Flamand A: Studies on pathogenicity in mice of rabies virus strains used for oral vaccination of foxes in Europe. In: Pastoret PP, Brochier B, Thomas I, Blancou J (eds): Vaccination to Control Rabies in foxes (La vaccination antirabique du renard). Commission of the European Communities, EUR 11439 EN-FR, 1988, pp 101–104.Google Scholar
  67. 67.
    Leblois H, Tuffereau C, Blancou J, Artois M, et al: Oral immunization of foxes with avirulent rabies virus mutants. Vet Micrbiol 1990; 23: 259–266.Google Scholar
  68. 68.
    Lentz TL, Wilson PT, Hawrot E, Speicher DW: Amino acid sequence similarity between rabies virus glycoprotein and snake venom curaromimetic neurotoxins. Science 1984; 226: 847–848.PubMedGoogle Scholar
  69. 69.
    Li J, Happ B, Schetter C, Oellig C, et al: The expression of the Autographa californica nuclear polyhedrosis virus genome in insect cells. In: Edwards S, Pastoret PP (eds): Advances in Veterinary Virology. Paris: Elsevier, 1990.Google Scholar
  70. 70.
    Lodmell DL: Genetic control of resistance to rabies. In: Campbell JB, Charlton K (eds): Rabies. Developments in Veterinary Virology. Dordrecht: Kluwer Academic Publishers, 1988.Google Scholar
  71. 71.
    Mayr A, Kraft H, Jaeger O, Haacke H: Orale Immuniesierung von Füchsen gegen Tollwut. Zentbl Vet Med 1972; 19B: 615–625.Google Scholar
  72. 72.
    McFarlan RI: Immune responses to rabies virus: vaccines and natural infection. In: Campbell JB, Charlton K (eds): Rabies. Developments in Veterinary Virology. Dordrecht: Kluwer Academic Publishers.Google Scholar
  73. 73.
    Metianu T: Vaccination antirabique par voie orale par des vaccins tués. Premiers résultats. Acad Vét Fr 1981; 56: 481–490.Google Scholar
  74. 74.
    Morein B, Sundquist B, Höglund S, Dalsgaard K, et al: Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature (London) 1984; 308: 457–460.Google Scholar
  75. 75.
    Morein B: Iscoms. In: Edwards S, Pastoret PP (eds): Advances in Veterinary Virology. Amsterdam: Elsevier, 1990.Google Scholar
  76. 76.
    Newmarket P: New vaccine and initiative mean end of rabies in sight for Europe? Nature (London) 1988; 336: 416.Google Scholar
  77. 77.
    Osterhaus ADME, Sunquist B, Morein B, Steenis G: Comparison of an experimental rabies iscom subunit vaccine with inactivated dog kidney cell vaccine. Proceedings of the First International Veterinary Immunology Symposium, Guelph, Canada, 1986.Google Scholar
  78. 78.
    Pasteur L, Roux E, Chamberland C, Thullier L: Sur la rage. CR Hebd Séanc Acad Sci Paris 1881; 92: 1259–1260.Google Scholar
  79. 79.
    Pasteur L, Chamberland C, Roux E: Sur la rage. CR Hebd Séanc Acad Sci, Paris 1884; 98: 1229–1231.Google Scholar
  80. 80.
    Pasteur L: Méthode pour prévenir la rage après morsure. CR Hebd Séanc Acad Sci Paris 1885; 101: 765–772.Google Scholar
  81. 81.
    Pastoret PP, Thomas I, Brochier B, Schwers A: Les problèmes associés à la vaccination antirabique des animaux domestiques. Ann Méd Vét 1985; 129: 361–374.Google Scholar
  82. 82.
    Pastoret PP, Schwers A, Thiriart C, Iokem A, et al: Vaccination antirabique des renardeaux à l’aide d’un virus inactivé. Rev Ecol (Terre et Vie) 1985; 40: 267–268.Google Scholar
  83. 83.
    Pastoret PP, Frisch R, Blancou J, Wolff F, et al: Campagne internationale de vaccination antirabique du renard par voie orale menée au grand-duché de Luxembourg, en Belgique et en France. Ann Méd Vét 1987; 131: 441–447.Google Scholar
  84. 84.
    Pastoret PP, Brochier B, Languet B, Thomas I, et al: First field trial of fox vaccination against rabies using a vaccinia-rabies recombinant virus. Vet Rec 1988; 123: 481–483.PubMedGoogle Scholar
  85. 85.
    Pastoret PP, Brochier B, Thomas I, Leveau T, et al: Fox rabies in Europe. Ir Vet J 1989; 42: 93–95.Google Scholar
  86. 86.
    Pastoret PP, Brochier B: Le virus de la vaccine et ses proches parents. Ann Méd Vét 1990; 134: 207–220.Google Scholar
  87. 87.
    Paulakis GN: Gene expression using DNA viral vectors. Current opinion in Biotechnology 1990; 1: 48–54.Google Scholar
  88. 88.
    Pepin M, Blancou J, Aubert MFA, Barrat J, et al: Oral immunization against rabies wih an avirulent mutant of the CVS strain: evaluation of its efficacy in fox (Vulpes vulpes) and its infectivity in seven other species. Ann Inst Pasteur/Virol 1985; 136E: 65–73.Google Scholar
  89. 89.
    Perrin P, Thibodeau L, Dauguet C, Fritsch A, et al: Enhancement of immunogenic and protective activity of rabies glycoprotein by anchorage on preformed liposomes. Ann Virol 1984; 135E: 183–199.Google Scholar
  90. 90.
    Plotkin SA, Wiktor TJ., Koprowski H, Rosanoff ES, et al: Immunization schedules for the new human diploid cell vaccine against rabies. Am J Epidemiol 1976; 103: 75–80.PubMedGoogle Scholar
  91. 91.
    Préhaud C, Takehara K, Flamand A, Bishop DHL: Immunogenic and protective properties of rabies virus glycoprotein expressed by baculovirus vectors. Virology 1989; 173: 390–399.PubMedGoogle Scholar
  92. 92.
    Reagan KJ, Wunner WH, Wiktor TJ., Koprowski H: Anti-idiotypic antibodies induce neutralizing antibodies to rabies virus glycoprotein. J Virol 1983; 48: 660–666.PubMedGoogle Scholar
  93. 93.
    Roux E: Note sur un moyen de conserver les moelles rabiques avec leur virulence. Ann Inst Pasteur Paris 1887; 1: 87.Google Scholar
  94. 94.
    Rupprecht CE, Wiktor TJ, Johnston DH, Hamir AN, et al: Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus-vaccine. Proc Natl Acad Sci USA 1986; 83: 7947–7950.PubMedGoogle Scholar
  95. 95.
    Rupprecht CE, Hamir AN, Johnston DH, Koprowski H: Efficacy of a vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor). Rev Infect Dis 1988; 10: 803–809.Google Scholar
  96. 96.
    Rupprecht CE, Charlton KM, Artois M, Casey GA, et al: Ineffectiveness and comparative pathogenicity of attenuated rabies virus vaccines for the striped skunk (Mephitis mephitis). J Wildl Dis 1990; 26: 99–102.PubMedGoogle Scholar
  97. 97.
    Schneider LG, Cox JH: Ein Feldversuch zur oralen Immunisierung von Füchsen gegen die Tollwut in der Bundesrepublik Deutschland. Tierärztl Umsch 1983; 5: 315–324.Google Scholar
  98. 98.
    Schneider LG: Oral immunization of wildlife against rabies. Ann Inst Pasteur/Virol 1985; 136E: 161–165.Google Scholar
  99. 99.
    Schneider LG, Cox JH, Wandeler AI, Blancou J, et al: Application of monoclonal antibodies for epidemiological investigations and oral vaccination studies. III. Oral rabies vaccines. In: Kuwert E, Mérieux C, Koprowski H, Bögel K (eds): Rabies in the Tropics. Berlin: Springer-Verlag, 1985, p 786.Google Scholar
  100. 100.
    Schneider LG, Cox JH, Müller WW, Hohnsbeen KP: Der Feldversuch zur oralen Immunisierung von Füchsen gegen die Tollwut in der Bundesrepublik Deutschland. Eine Zwischenbilanz. Tierärztl Umsch 1987; 42: 184–198.Google Scholar
  101. 101.
    Seif I, Coulon P, Rollin P, Flamand A: Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J Virol 1985; 53: 926.PubMedGoogle Scholar
  102. 102.
    Selimov MA: Oral immunization of polar foxes (Alopex lagopus) and raccoon dogs (Nyctereutes procyonoides) against rabies. Rabies Inf Exch 1987; 16: 1–4.Google Scholar
  103. 103.
    Sample D: The preparation of safe and efficient antirabic vaccine. Sci Mem Med Sanit Dept Gout India Bull Inst Pasteur Paris 1911; 9: 701.Google Scholar
  104. 104.
    Soulebot JP, Precausta P, Burn A, Chappuis G, et al: Prophylaxie de la rage animale (ou vétérinaire) par un vaccin inactivé monovalent ou associé. Dev Biol Standard 1978; 41: 389–399.Google Scholar
  105. 105.
    Spittler K: Untersuchungen über die Möglichkeiten des Lebendfangs von Füchsen zur Immunisierung gegen Tollwut Z Jagdwiss 1976; 22: 161–169.Google Scholar
  106. 106.
    Steck F, Wandeler Al, Capt S., Hafliger U, et al: Oral immunization of foxes against rabies. Laboratory and field studies. Comp Immun Microbiol infect Dis 1982; 5: 165–171.Google Scholar
  107. 107.
    Steck F, Wandeler AI, Bichsel P, Capt S, et al: Oral immunization of foxes against rabies. A field study. Zentbl Vet Med 1982; 29: 372–396.Google Scholar
  108. 108.
    Sureau P: La vaccination contre la rage. La recherche 1985; 16: 874–882.Google Scholar
  109. 109.
    Taylor J, Wainberg R, Languet B, Desmettre P, et al: Recombinant fowlpox virus inducing protective immunity in non-avian species. Vaccine 1988; 6: 497–503.PubMedGoogle Scholar
  110. 110.
    Taylor J, Trimarchi C, Weinberg R, Languet B, et al: Efficacy studies on a canarypox rabies recombinant virus. Vaccine 1991; 9: 190–193.PubMedGoogle Scholar
  111. 111.
    Theodorides J: Histoire de la rage (Cave canem). Paris: Masson, 1986.Google Scholar
  112. 112.
    Thibodeau L, Perrin P, Sureau P: Rabies immunosomes: candidate for an RNA-free vaccine. In. Chanock RM, Lerner F (eds): Modern Approaches to Vaccines: Molecular and Chemical Basis of Virus Virulence and Immunogenicity. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1984, pp 373–377.Google Scholar
  113. 113.
    Thiriart C, Iokem A, Costy F, Schwers A, et al: Immunization of young foxes against rabies: Interaction between vaccination and natural infection. Ann Rech Vet 1985; 16: 289–292.PubMedGoogle Scholar
  114. 114.
    Thomas I, Brochier B, Languet B, Péharpré D, et al: Multiplication site of the vacciniarabies glycoprotein recombinant virus administered by the oral route in foxes. J Gen Virol 1990; 71: 37–42.PubMedGoogle Scholar
  115. 115.
    Tidke R, Préhud C, Coulon P, Blancou J, et al: Characterization of a double avirulent mutant of rabies virus and its potency as a vaccine, live or inactivated. Vaccine 1987; 5: 229–233.PubMedGoogle Scholar
  116. 116.
    Tolson ND, Charlton KM, Stewart RB, Campbell JB, et al: Immune response in skunks to a vaccinia virus recombinant expressing the rabies virus glycoprotein. Can J Vet Res 1987; 51: 363–366.PubMedGoogle Scholar
  117. 117.
    Tordo N, Poc P, Ermine A, Keith G, et al.: Molecular genetics of the rabies virus, a century after Pasteur. In: Schwartz M (ed): Molecular Biology and Infectious Diseases, Amsterdam: Elsevier, 1988.Google Scholar
  118. 118.
    Tuffereau C, Leblois H, Benejean J, Coulon P, et al: Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice. Virology 1989; 172: 206–212.PubMedGoogle Scholar
  119. 119.
    Umeno S, Doi Y: The study of the anti-rabic inoculation of dogs and the results of its practical application. Kitasato Arch Exp Med 1921; 4: 89–105.Google Scholar
  120. 120.
    Wachendorfer G: Gegenwärtiger Stand der Vakzination von Füchsen gegen Tollwut. Prakt Tierärztl 1976; 57: 801–807.Google Scholar
  121. 121.
    Wachendorfer G, Frost J, Gutman B, Eskens U, et al: Preliminary results of a field trial in Hesse (FRG) to control fox rabies by oral immunization. Rev Ecol (Terre et Vie) 1985; 40: 257–263.Google Scholar
  122. 122.
    Wachendorfer G, Frost J, Gurman B, Eskens V, et al: Erfrahrungen mit der oralen Immunisierung von Füchsen gegen Tollwut in Hessen. Tierärztl Prax 1986; 14: 185–196.PubMedGoogle Scholar
  123. 123.
    Whetstone CA, Bunn TO, Emmons RW, Wiktor TJ: Use of monoclonal antibodies to confirm vaccine-induced rabies in ten dogs, two cats and one fox. J Am Vet Med Assoc 1984; 185: 285–288.PubMedGoogle Scholar
  124. 124.
    Wiktor TJ, Fernandes MV, Koprowski H: Cultivation of rabies virus in human diploid cell strain WI 38. J Immun 1964; 93: 353–366.PubMedGoogle Scholar
  125. 125.
    Wiktor TJ, Sokol F, Kuwert E, Koprowski H: Immunogenicity of concentrated and purified rabies vaccine of tissue culture origin. Proc Soc Exp Biol Med 1969; 131: 799–805.PubMedGoogle Scholar
  126. 126.
    Wiktor TJ, Dietzschold B, Leamson RN, Koprowski H: Induction and biological properties of defective interfering particles of rabies virus. J Virol 1977; 21: 626–635.PubMedGoogle Scholar
  127. 127.
    Wiktor TJ: Virus vaccines and therapeutic approaches. In: Bishop DH (ed): Rhabdoviruses, Vol. 3. Boca Raton: CRC Press, 1979, pp 99–112.Google Scholar
  128. 128.
    Wiktor TJ, Flamand A, Koprowski H. Use of monoclonal antibodies in diagnosis of rabies virus infection and differentiation of rabies and rabies-related viruses. J Virol Methods 1980; 1: 33–46.Google Scholar
  129. 129.
    Wiktor TJ, McFarlan R, Reagan K, Dietzschold D, et al: Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc Natl Acad Sci USA 1984; 81: 7194–7198.PubMedGoogle Scholar
  130. 130.
    Winkler WG, Baer GM: Rabies immunization of red foxes (Vulpes vulpes) with vaccine in sausage baits. Am J Epidemiol 1976; 103: 408–415.PubMedGoogle Scholar
  131. 131.
    Winkler WG, Shaddock JH, Williams LW: Oral rabies vaccine: evaluation of its infectivity in three species of rodents. Am J Epidemiol 1976; 104: 294–298.PubMedGoogle Scholar
  132. 132.
    Wunner WH, Larson JK, Dietzschold B, Smith CL: The molecular biology of rabies viruses. Rev Infect Dis 1988; 10: S771 - S784.PubMedGoogle Scholar
  133. 133.
    Zinke G: Neue Ansichten der Hundswut, ihrer Ursachen and Folgen nebst einer sichern Behanlungsart der von tollen Tieren gebissenen Menschen. Gabler Jena 1804; 16: 212.Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1993

Authors and Affiliations

  • Paul Pierre Pastoret
  • Bernard Brochier
  • Gille Chappuis
  • Philippe Desmettre

There are no affiliations available

Personalised recommendations